TrianglePUBLICATIONS · 19738129
Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myeloma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Oct 20
- First author
- Jakubowiak AJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Jakubowiak AJ
- type
- Author
- name
- Kendall T
- type
- Author
- name
- Al-Zoubi A
- type
- Author
- name
- Khaled Y
- type
- Author
- name
- Mineishi S
- type
- Author
- name
- Ahmed A
- type
- Author
- name
- Campagnaro E
- type
- Author
- name
- Brozo C
- type
- Author
- name
- Braun T
- type
- Author
- name
- Talpaz M
- type
- Author
- name
- Kaminski MS
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Jakubowiak AJ
- type
- Author
- name
- Kendall T
- type
- Author
- name
- Al-Zoubi A
- type
- Author
- name
- Khaled Y
- type
- Author
- name
- Mineishi S
- type
- Author
- name
- Ahmed A
- type
- Author
- name
- Campagnaro E
- type
- Author
- name
- Brozo C
- type
- Author
- name
- Braun T
- type
- Author
- name
- Talpaz M
- type
- Author
- name
- Kaminski MS
- type
- Author
- bibliography ids
- nci-bib-ba26bab09cec84e991f738f4
- book metadata
- content sha256
- 5b88e8f9520f0024d20f4b0e31e88839e72e31fee1e2e4cdd8d9c43f116bb589
- document type
- citation
- dois
- 10.1200/JCO.2008.19.5370
- electronic publication date
- display
- 2009 Sep 8
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19738129
- immutable id
- pubmed:19738129@5b88e8f9520f0024d20f4b0e31e88839e72e31fee1e2e4cdd8d9c43f116bb589
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 30
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 5015-22
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19738129
- provenance
- batch id
- 0706b5111d1451f52f74
- provider
- NCBI PubMed ESummary
- record sha256
- 590db55cd21ce7c0a7e818abba0d473b912cc657ec2995818f588c9a69099deb
- response sha256
- 98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
- retrieved at
- 2026-09-09T23:46:29.215195+00:00
- publication date
- display
- 2009 Oct 20
- precision
- day
- year
- 2009
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myeloma.
Preserved source evidence · Not medical advice